Butalbital, Acetaminophen, And Caffeine Capsule
Product Images NDC 0591-2640

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Butalbital, Acetaminophen, And Caffeine (NDC 0591-2640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Butalbital Sf (Image 1)

Butalbital Sf (Image 1)
This is not a descriptive text. These are technical specifications of a chemical compound, likely a molecular formula and molecular weight. It is not possible to generate a useful description with this information alone.*
FDA Label Image

Acetaminophen Sf (Image 2)

Acetaminophen Sf (Image 2)
The given text "CgHoNO, MW 151.16" appears to be chemical notation. "CgHoNO" represents a chemical compound or molecule, but without any additional information, it is not identifiable. "MW 151.16" could be the molecular weight or mass of the notation. However, without context, it is not possible to provide a meaningful description. Therefore, the description cannot be generated using this information alone.*
FDA Label Image

Caffeine Sf (Image 3)

Caffeine Sf (Image 3)
FDA Label Image

Watson 3 Heads Imprint (Image 4)

Watson 3 Heads Imprint (Image 4)
FDA Label Image

Image 100 Ct (Image 5)

Image 100 Ct (Image 5)
This is a description of Teva Butalbital, Acetaminophen, and Caffeine Capsules, which are prescription-only drugs, containing Butalbital, Acetaminophen, and Caffeine, USP, with butalbital potentially causing habit-forming. These capsules come in a tight container, and the recommended adult dosage is 1 or 2 capsules every 4 hours, with a total daily dose not exceeding b capsules. LGM Pharma Solutions, LLC manufactures them for Teva Pharmaceuticals USA, Inc. They should be stored at temperatures between 20 to 25°C. A package insert is available for additional prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.